Spanish Tennis’ long doping history
Testosterone use dates back to a Davis Cup tie in 1959 and there have been twelve doping cases in Spanish tennis since 1996, one involving a minor.


On 10th July 1959, a weary, defeated Andres Gimeno trudged off centre court at the Barcelona Royal Tennis Club. The Spanish player had just wilted in the scorching heat during a five-set Davis Cup doubles match against Great Britain. Gimeno’s physical collapse in the final set, described by the press as a “cessation of effort”, led to his doubles team’s downfall.
Twenty-four hours later, during his singles tie, Gimeno miraculously recovered and wore down Britain’s Billy Knight with his “big forehand, precise volleying and astute lobbing”. The Daily Mail reported that Gimeno, known as the Barcelona Matador, was still “much the fitter man at the end” despite the 45-degree heat.
Spanish legend and 1966 Wimbledon champion Manolo Santana went on to seal victory in the tie for Spain.
But how did Gimeno, Roland Garros’ oldest ever champion, rise from the dead?
In the aftermath of the tie, Dr. Vidal Saval, physician to the Barcelona Royal Tennis Club, now home to the annual ATP 500 clay event and many of Spain’s top players, candidly told The Daily Sketch that he had put Gimeno, just 20 at the time, on “an intensive regime of injections of testosterone” to recover.
Gimeno’s story was splashed across the British press with headlines reading: “Gemino (sic) was drugged”; “Davis Cup Sensation: ‘Pep’ jabs helped Spain win”; “Don’t monkey around with testosterone for tennis”.
The then-president of the Royal Spanish Tennis Federation (RFET), the Marques of Cabanes, confirmed that the injections had been given. The chairman of the Lawn Tennis Association Mr. W. J. Greener described the use of hormone injections as “rather unfair” despite testosterone injections not being against the rules at the time.
And so began Spanish tennis’ chequered doping history.


Andres Gimeno (far left) pictured during a tribute tournament to Gimeno in 2011 involving the likes of Rafael Nadal and David Ferrer. (Source: Facebook)
Some forty years later, in 1996, Spain’s Ignacio Truyol became the first ever tennis player to test positive for anabolic steroids. Truyol, who was Fernando Verdasco’s coach up until last year, tested positive for nandrolone and the stimulant pemoline at a tournament in Belgium. He claimed he had been given the drugs by a Spanish endocrinologist, Carlos R. Jimenez, to treat a chronic back injury – he was banned for two years.
Truyol’s case broke when drug testing in sport was as blunt as a butter knife, and drug testing in tennis was as blunt as its wooden handle. In fact, the sport’s anti-doping programme has only become adequate in the last few years. As recently as 2012 the International Tennis Federation (ITF) were annually only performing 38 out-of-competition tests for the game-changing blood booster EPO and just 8 confirmatory tests for synthetic testosterone.
Yet Spanish tennis has still managed to have plentiful run-ins with anti-doping protocols. Further plumes of smoke have aroused more suspicion of unfair competition.
There have been twelve doping cases involving Spanish players since 1996.
Four of those banned were ranked inside the top 100 during their careers. Nuria Llagostera Vives, from Mallorca, reached number 35 in the world rankings while Juan Viloca crept inside the top 50 before becoming the coach of two-time grand slam champion Svetlana Kuznetsova. Only Italy, Brazil and Argentina, whose elite players often base themselves out of Spain, have had comparable problems.
Three of these Spanish players were defended at their disciplinary hearings by the sports lawyer Fermin Morales’ law firm. Morales later became the president of the Spanish Tennis Federation’s anti-doping commission, a position he has held for the last decade.


Leave A Comment